ObesityObesity is a disease that has historically eluded effective medical therapy. Prior to 2012, phentermine and orlistat were the only medications available to treat obesity in the USA, with phentermine approved only for short-term use. However, as of 2015, the repertoire of pharmacological ...
CNN: How promising are these drugs to treat obesity? Wen:Of the two medications, semaglutide is the one that’s better studied. A 2022 study, published inJAMA Network Open, found that study participants’ mean weight loss after taking it for three months was 6.7 kilograms (14.8 pounds), or...
Obesity is a disease that has historically eluded effective medical therapy. Prior to 2012, phentermine and orlistat were the only medications available to treat obesity in the USA, with phentermine approved only for short-term use. However, as of 2015, the repertoire of pharmacological agents avai...
Weight loss can reduce mortality and improve most of the detrimental health consequences of obesity. Design and Methods: This paper was developed from two presentations to the US Food and Drug Administration (FDA), which has responsibility for reviewing and approving drugs to treat obesity. Results...
obesity — n. 肥胖,以一种不健康的方式过于肥胖 recur — v. 再次发生或出现 ideation — n. 想法或概念的形成 prescribe — v. 官方指定某人使用某种疗法或治疗方法 consistent — adj. 总是以相同的方式行动或表现 diverse — adj. 彼此不同的
Two major US healthcare organisations have offered contradictory advice about the use of weight loss drugs in adolescents with obesity, underscoring just how little we know about the effects of these medications
Metformin is considered the first-line oral agent for patients with diabetes and can be used to treat pre-diabetes. It works by decreasing glucose production in the liver, increasing insulin sensitivity, and lowering intestinal sugar absorption. Metformin has been shown to decrease A1 levels by 1%...
(Medical Xpress)—An international study led by a researcher from The University of Western Australia for the Western Australian Institute for Medical Research (WAIMR) has produced exciting results that may lead to new drugs to treat obesity and reduce the incidence of Type 2 diabetes. ...
Promising news in the effort to develop drugs to treat obesity comes from University of Virginia scientists who have identified 14 genes that can cause weight gain and three that can prevent it. The findings pave the way for treatments to combat a health problem that affects more than 40% of...
Novo Nordisk then launched Wegovy, which has the sameactive ingredientas Ozempic in a different dose, but which was approved by US regulators to treat obesity. Wegovy is also marketed in Denmark, Norway, the United Kingdom and Germany.